These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12620402)

  • 21. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling.
    Vazquez F; Sellers WR
    Biochim Biophys Acta; 2000 Feb; 1470(1):M21-35. PubMed ID: 10656987
    [No Abstract]   [Full Text] [Related]  

  • 22. The multiple roles of PTEN in tumor suppression.
    Di Cristofano A; Pandolfi PP
    Cell; 2000 Feb; 100(4):387-90. PubMed ID: 10693755
    [No Abstract]   [Full Text] [Related]  

  • 23. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
    Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
    Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumorigenesis facilitated by Pten deficiency in the skin: evidence of p53-Pten complex formation on the initiation phase.
    Komazawa N; Suzuki A; Sano S; Horie K; Matsuura N; Mak TW; Nakano T; Takeda J; Kondoh G
    Cancer Sci; 2004 Aug; 95(8):639-43. PubMed ID: 15298725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTEN function in mammalian cell size regulation.
    Backman S; Stambolic V; Mak T
    Curr Opin Neurobiol; 2002 Oct; 12(5):516-22. PubMed ID: 12367630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.
    Li DM; Sun H
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15406-11. PubMed ID: 9860981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor suppressor genes in lung cancer.
    Virmani AK; Gazdar AF
    Methods Mol Biol; 2003; 222():97-115. PubMed ID: 12710682
    [No Abstract]   [Full Text] [Related]  

  • 28. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
    Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
    Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of TP53 and PTEN in gliomatosis cerebri.
    Mawrin C; Kirches E; Schneider-Stock R; Scherlach C; Vorwerk C; Von Deimling A; Van Landeghem F; Meyermann R; Bornemann A; Müller A; Romeike B; Stoltenburg-Didinger G; Wickboldt J; Pilz P; Dietzmann K
    Acta Neuropathol; 2003 Jun; 105(6):529-36. PubMed ID: 12734658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse models in tumor suppression.
    Ghebranious N; Donehower LA
    Oncogene; 1998 Dec; 17(25):3385-400. PubMed ID: 9917000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation.
    Xiao A; Wu H; Pandolfi PP; Louis DN; Van Dyke T
    Cancer Cell; 2002 Mar; 1(2):157-68. PubMed ID: 12086874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The coordinate regulation of the p53 and mTOR pathways in cells.
    Feng Z; Zhang H; Levine AJ; Jin S
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8204-9. PubMed ID: 15928081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment and characterization of nine human brain tumor cell lines.
    Shin KH; Choe G; Park YJ; Jang JH; Jung HW; Park JG
    In Vitro Cell Dev Biol Anim; 2001; 37(10):625-8. PubMed ID: 11776963
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice.
    You MJ; Castrillon DH; Bastian BC; O'Hagan RC; Bosenberg MW; Parsons R; Chin L; DePinho RA
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1455-60. PubMed ID: 11818530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Ptentative nature of mouse knockouts.
    Bradley A; Luo G
    Nat Genet; 1998 Dec; 20(4):322-3. PubMed ID: 9843198
    [No Abstract]   [Full Text] [Related]  

  • 36. Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.
    Lesche R; Groszer M; Gao J; Wang Y; Messing A; Sun H; Liu X; Wu H
    Genesis; 2002 Feb; 32(2):148-9. PubMed ID: 11857804
    [No Abstract]   [Full Text] [Related]  

  • 37. [Expression of phosphatase and tensin homology deleted on chromosome ten(PTEN) and p53 protein and their significance in human hepatocellular carcinomas].
    Cheng LM; Wang SY; Lin JS
    Ai Zheng; 2003 Jan; 22(1):42-5. PubMed ID: 12561434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between DNA content and tumor suppressor gene expression and aggressiveness of atypical teratoid/rhabdoid tumors.
    Berrak SG; Ozek MM; Canpolat C; Dağçinar A; Sav A; El-Naggar A; Langford LA
    Childs Nerv Syst; 2002 Oct; 18(9-10):485-91. PubMed ID: 12382173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region.
    Sheng X; Koul D; Liu JL; Liu TJ; Yung WK
    Biochem Biophys Res Commun; 2002 Mar; 292(2):422-6. PubMed ID: 11906179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTEN "meets" DMSO.
    Santos NC; Martins-Silva J; Saldanha C
    Leuk Res; 2005 Apr; 29(4):361-2. PubMed ID: 15725467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.